I was on death's door and had a groundbreaking op. They said my new organ would last for a couple of years at best. But 50 years later, it's still going strong... thanks to ...
When Mike Shepherdson had a life-saving kidney transplant at the age of 13, the expectation was that, at best, it would work ...
thecardiologyadvisor.com9h
Empagliflozin, Dapagliflozin Comparably Reduce AKI, CKD Risks in Diabetes Population
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.
Daily9h
Early ICU Transfer and Trauma Severity may predict Dialysis Dependence in kids with Earthquake-Related Crush Injury: JAMA
A new study published in JAMA Network Open has found that among children affected by the crush syndrome due to the 2023 ...
emjreviews.com16h
Lupus Vasculitis, A Rare Diagnosis and a Therapeutic Challenge: A Case Report
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
UroToday5h
ASCO GU 2025: Safety Profile of Lutetium-177 in Patients with Impaired Renal Function: A Retrospective Analysis of Adverse Events in mCRPC Treatment.
Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment. Dr. Saylani highlighted that Lutetium-177 vipivotide tetraxetan ...